Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q3 2024 · 10-Q
Revenue$589.13M$589.13M+6.5% vs Q3 2023 Net Income-$32.98M-$32.98MN/M vs Q3 2023 EPS Diluted-$1.35-$1.35N/M vs Q3 2023 Gross Profit$204,852,000+11.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$36,097,000+2.7% Free Cash Flowderived$16,187,000+18.2% Margins · derivedGross margin34.8%+1.5 pt vs Q3 2023
Operating margin1.4%−2.7 pt vs Q3 2023
Net margin-5.6%−6.9 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end